{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T02:35:21Z","timestamp":1791858921406,"version":"4.3.4"},"reference-count":113,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2019,4,9]],"date-time":"2019-04-09T00:00:00Z","timestamp":1554768000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pediatr."],"DOI":"10.3389\/fped.2019.00133","type":"journal-article","created":{"date-parts":[[2019,4,9]],"date-time":"2019-04-09T06:44:58Z","timestamp":1554792298000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":112,"title":["Transplant-Associated Thrombotic Microangiopathy in Pediatric Hematopoietic Cell Transplant Recipients: A Practical Approach to Diagnosis and Management"],"prefix":"10.3389","volume":"7","author":[{"given":"Christopher C.","family":"Dvorak","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Higham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristin A.","family":"Shimano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2019,4,9]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.blre.2014.11.001","article-title":"A new paradigm: diagnosis and management of HSCT-associated thrombotic microangiopathy as multi-system endothelial injury","volume":"29","author":"Jodele","year":"2015","journal-title":"Blood Rev"},{"key":"B2","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1182\/blood-2014-03-564997","article-title":"Diagnostic and risk criteria for HSCT-associated thrombotic microangiopathy: a study in children and young adults","volume":"124","author":"Jodele","year":"2014","journal-title":"Blood"},{"key":"B3","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1097\/TP.0b013e3181f24e8d","article-title":"Validation of recently proposed consensus criteria for thrombotic microangiopathy after allogeneic hematopoietic stem-cell transplantation","volume":"90","author":"Cho","year":"2010","journal-title":"Transplantation"},{"key":"B4","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1016\/j.bbmt.2005.06.001","article-title":"Blood and marrow transplant clinical trials Network Toxicity Committee consensus summary: thrombotic microangiopathy after hematopoietic stem cell transplantation","volume":"11","author":"Ho","year":"2005","journal-title":"Biol Blood Marrow Transplant"},{"key":"B5","doi-asserted-by":"publisher","first-page":"95","DOI":"10.3324\/haematol.10699","article-title":"Diagnostic criteria for hematopoietic stem cell transplant-associated microangiopathy: results of a consensus process by an International Working Group","volume":"92","author":"Ruutu","year":"2007","journal-title":"Haematologica."},{"key":"B6","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1016\/j.bbmt.2006.11.020","article-title":"Transplant-associated microangiopathy in patients receiving tacrolimus following allogeneic stem cell transplantation: risk factors and response to treatment","volume":"13","author":"Oran","year":"2007","journal-title":"Biol Blood Marrow Transplant"},{"key":"B7","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1038\/sj.bmt.1705976","article-title":"Clinical impact of thrombotic microangiopathy on the outcome of patients with acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation","volume":"41","author":"Cho","year":"2008","journal-title":"Bone Marrow Transplant"},{"key":"B8","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1111\/j.1365-2141.2006.06126.x","article-title":"Prospective study on the behaviour of the metalloprotease ADAMTS13 and of von Willebrand factor after bone marrow transplantation","volume":"134","author":"Peyvandi","year":"2006","journal-title":"Br J Haematol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"3637","DOI":"10.1182\/blood-2015-02-629683","article-title":"Modified Ham test for atypical hemolytic uremic syndrome","volume":"125","author":"Gavriilaki","year":"2015","journal-title":"Blood."},{"key":"B10","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1053\/j.ajkd.2006.06.013","article-title":"Circulating endothelial cells as a prognostic marker in thrombotic microangiopathy","volume":"48","author":"Erdbruegger","year":"2006","journal-title":"Am J Kidney Dis."},{"key":"B11","doi-asserted-by":"publisher","first-page":"1405","DOI":"10.1097\/01.tp.0000209218.24916.ba","article-title":"Endothelial cell\u2013derived microparticles in allogeneic hematopoietic stem cell recipients","volume":"81","author":"Pihusch","year":"2006","journal-title":"Transplantation."},{"key":"B12","doi-asserted-by":"publisher","first-page":"1259","DOI":"10.1182\/blood-2017-05-782870","article-title":"Circulating dsDNA, endothelial injury, and complement activation in thrombotic microangiopathy and GVHD","volume":"130","author":"Gloude","year":"2017","journal-title":"Blood."},{"key":"B13","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.1111\/jth.13661","article-title":"Effects of alloantibodies to human leukocyte antigen on endothelial expression and serum levels of thrombomodulin","volume":"15","author":"B\u00e9land","year":"2017","journal-title":"J Thromb Haemost."},{"key":"B14","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1097\/TP.0b013e31829807aa","article-title":"Renal arteriolar C4d deposition: a novel characteristic of hematopoietic stem cell transplantation\u2013associated thrombotic microangiopathy","volume":"96","author":"Laskin","year":"2013","journal-title":"Transplantation"},{"key":"B15","doi-asserted-by":"publisher","first-page":"1558","DOI":"10.5858\/arpa.2016-0599-RA","article-title":"A complete histologic approach to gastrointestinal biopsy from hematopoietic stem cell transplant patients with evidence of transplant-associated gastrointestinal thrombotic microangiopathy","volume":"141","author":"Warren","year":"2017","journal-title":"Arch Pathol Lab Med."},{"key":"B16","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1097\/01.tp.0000230373.82376.46","article-title":"Risk factors and severe outcome in thrombotic microangiopathy after allogeneic hematopoietic stem cell transplantation","volume":"82","author":"Uderzo","year":"2006","journal-title":"Transplantation"},{"key":"B17","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/S1473-0502(02)00020-4","article-title":"Transplantation-associated thrombotic microangiopathy is associated with transplantation from unrelated donors, acute graft-versus-host disease and venoocclusive disease of the liver","volume":"27","author":"Daly","year":"2002","journal-title":"Transfus Apher Sci."},{"key":"B18","doi-asserted-by":"publisher","first-page":"1311","DOI":"10.1038\/s41409-018-0159-8","article-title":"High-dose Carboplatin\/Etoposide\/Melphalan increases risk of thrombotic microangiopathy and organ injury after autologous stem cell transplantation in patients with neuroblastoma","volume":"53","author":"Jodele","year":"2018","journal-title":"Bone Marrow Transplant"},{"key":"B19","doi-asserted-by":"publisher","first-page":"1452","DOI":"10.1182\/blood-2011-02-321315","article-title":"Small vessels, big trouble in the kidneys and beyond: hematopoietic stem cell transplantation\u2013associated thrombotic microangiopathy","volume":"118","author":"Laskin","year":"2011","journal-title":"Blood."},{"key":"B20","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1038\/bmt.2017.161","article-title":"Diagnosis and severity criteria for sinusoidal obstruction syndrome\/veno-occlusive disease in pediatric patients: a new classification from the European society for blood and marrow transplantation","volume":"53","author":"Corbacioglu","year":"2017","journal-title":"Bone Marrow Transplant."},{"key":"B21","doi-asserted-by":"publisher","first-page":"1573","DOI":"10.1016\/j.bbmt.2016.05.018","article-title":"A novel diagnostic and prognostic biomarker panel for endothelial cell damage\u2013related complications in allogeneic transplantation","volume":"22","author":"Tatekawa","year":"2016","journal-title":"Biol Blood Marrow Transplant."},{"key":"B22","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/0049-3848(92)90286-J","article-title":"Increased levels of tissue plasminogen activator (t-PA) and tissue plasminogen activator inhibitor (PAI) correlate with tumor necrosis factor alpha (TNF alpha)-release in patients suffering from microangiopathy following allogeneic bone marrow transplantation (BMT)","volume":"66","author":"Seeber","year":"1992","journal-title":"Thromb Res."},{"key":"B23","doi-asserted-by":"publisher","first-page":"2056","DOI":"10.1016\/j.bbmt.2014.07.008","article-title":"Estimated versus measured glomerular filtration rate in children before hematopoietic cell transplantation","volume":"20","author":"Laskin","year":"2014","journal-title":"Biol Blood Marrow Transplant."},{"key":"B24","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/s40164-018-0106-9","article-title":"Bone marrow transplant-associated thrombotic microangiopathy without peripheral blood schistocytes: a case report and review of the literature","volume":"7","author":"Wirtschafter","year":"2018","journal-title":"Exp Hematol Oncol."},{"key":"B25","doi-asserted-by":"publisher","first-page":"1994","DOI":"10.1016\/j.bbmt.2015.06.016","article-title":"Histologic features of intestinal thrombotic microangiopathy in pediatric and young adult patients after hematopoietic stem cell transplantation","volume":"21","author":"El-Bietar","year":"2015","journal-title":"Biol Blood Marrow Transplant."},{"key":"B26","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.1016\/j.bbmt.2017.03.028","article-title":"Pericardial effusion following hematopoietic cell transplantation in children and young adults is associated with increased risk of mortality","volume":"23","author":"Cox","year":"2017","journal-title":"Biol Blood Marrow Transplant."},{"key":"B27","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.bbmt.2014.09.028","article-title":"Abnormal echocardiography 7 days after stem cell transplantation may be an early indicator of thrombotic microangiopathy","volume":"21","author":"Dandoy","year":"2015","journal-title":"Biol Blood Marrow Transplant."},{"key":"B28","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1016\/j.bbmt.2012.08.022","article-title":"Pulmonary arterial hypertension in pediatric patients with hematopoietic stem cell transplant\u2013associated thrombotic microangiopathy","volume":"19","author":"Jodele","year":"2013","journal-title":"Biol Blood Marrow Transplant."},{"key":"B29","doi-asserted-by":"publisher","first-page":"3733","DOI":"10.1182\/blood-2013-12-547067","article-title":"Biomarkers of terminal complement activation confirm the diagnosis of aHUS and differentiate aHUS from TTP","volume":"123","author":"Cataland","year":"2014","journal-title":"Blood."},{"key":"B30","doi-asserted-by":"publisher","first-page":"e26503","DOI":"10.1002\/pbc.26503","article-title":"Severe transplant-associated thrombotic microangiopathy in patients with hemoglobinopathies","volume":"64","author":"Abusin","year":"2017","journal-title":"Pediatr Blood Cancer."},{"key":"B31","doi-asserted-by":"publisher","first-page":"2003","DOI":"10.1182\/blood-2013-05-501445","article-title":"Abnormalities in the alternative pathway of complement in children with hematopoietic stem cell transplant-associated thrombotic microangiopathy","volume":"122","author":"Jodele","year":"2013","journal-title":"Blood."},{"key":"B32","doi-asserted-by":"publisher","first-page":"1457","DOI":"10.1111\/ctr.12840","article-title":"ABO blood group antigen mismatch has an impact on outcome after allogeneic peripheral blood stem cell transplantation","volume":"30","author":"Grube","year":"2016","journal-title":"Clin Transplant."},{"key":"B33","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.molimm.2015.03.246","article-title":"Atypical aHUS: state of the art","volume":"67","author":"Nester","year":"2015","journal-title":"Mol Immunol."},{"key":"B34","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1182\/blood-2015-08-663435","article-title":"The genetic fingerprint of susceptibility for transplant-associated thrombotic microangiopathy","volume":"127","author":"Jodele","year":"2016","journal-title":"Blood."},{"key":"B35","doi-asserted-by":"publisher","first-page":"1580","DOI":"10.1016\/j.bbmt.2017.05.013","article-title":"Acquired complement regulatory gene mutations and hematopoietic stem cell transplant\u2013related thrombotic microangiopathy","volume":"23","author":"Ardissino","year":"2017","journal-title":"Biol Blood Marrow Transplant."},{"key":"B36","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1200\/JCO.2017.76.4662","article-title":"Single nucleotide polymorphisms in CD40L predict endothelial complications and mortality after allogeneic stem-cell transplantation","volume":"36","author":"Rachakonda","year":"2018","journal-title":"J Clin Oncol."},{"key":"B37","doi-asserted-by":"publisher","first-page":"1321","DOI":"10.1038\/bmt.2015.161","article-title":"The potential role of HLA-DRB1*11 in the development and outcome of haematopoietic stem cell transplantation-associated thrombotic microangiopathy","volume":"50","author":"Balassa","year":"2015","journal-title":"Bone Marrow Transplant."},{"key":"B38","doi-asserted-by":"publisher","first-page":"1399","DOI":"10.1038\/bmt.2017.119","article-title":"Transplant-associated thrombotic microangiopathy is an endothelial complication associated with refractoriness of acute GvHD","volume":"52","author":"Zeisbrich","year":"2017","journal-title":"Bone Marrow Transplant."},{"key":"B39","doi-asserted-by":"publisher","first-page":"2344","DOI":"10.1016\/j.bbmt.2018.05.010","article-title":"Impact of thrombotic microangiopathy on renal outcomes and survival after hematopoietic stem cell transplantation","volume":"24","author":"Postalcioglu","year":"2018","journal-title":"Biol Blood Marrow Transplant."},{"key":"B40","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1002\/ajh.20648","article-title":"Risk factor analysis for thrombotic microangiopathy after reduced-intensity or myeloablative allogeneic hematopoietic stem cell transplantation","volume":"81","author":"Nakamae","year":"2006","journal-title":"Am J Hematol."},{"key":"B41","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1038\/bmt.2009.230","article-title":"Comparison of thrombotic microangiopathy after allogeneic hematopoietic cell transplantation with high-dose or nonmyeloablative conditioning","volume":"45","author":"Willems","year":"2009","journal-title":"Bone Marrow Transplant"},{"key":"B42","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1016\/j.bbmt.2014.12.036","article-title":"ABO mismatch is associated with increased nonrelapse mortality after allogeneic hematopoietic cell transplantation","volume":"21","author":"Logan","year":"2015","journal-title":"Biol Blood Marrow Transplant"},{"key":"B43","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.1046\/j.1537-2995.2003.00465.x","article-title":"ABO mismatch increases transplant-related morbidity and mortality in patients given nonmyeloablative allogeneic HPC transplantation","volume":"43","author":"Worel","year":"2003","journal-title":"Transfusion."},{"key":"B44","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/j.transci.2007.03.004","article-title":"ABO-incompatible allogeneic hematopoietic stem cell transplantation following reduced-intensity conditioning: close association with transplant-associated microangiopathy","volume":"36","author":"Worel","year":"2007","journal-title":"Transfus Apher Sci."},{"key":"B45","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1097\/01.tp.0000167758.63247.f4","article-title":"Platelet transfusion containing ABO-incompatible plasma and hepatic veno-occlusive disease after hematopoietic transplantation in young children","volume":"80","author":"Lapierre","year":"2005","journal-title":"Transplantation."},{"key":"B46","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1016\/j.bbmt.2012.10.006","article-title":"Thrombotic microangiopathy associated with sirolimus level after allogeneic hematopoietic cell transplantation with tacrolimus\/sirolimus-based graft-versus-host disease prophylaxis","volume":"19","author":"Shayani","year":"2013","journal-title":"Biol Blood Marrow Transplant."},{"key":"B47","doi-asserted-by":"publisher","first-page":"976","DOI":"10.1016\/j.bbmt.2010.02.006","article-title":"Chronic kidney disease, thrombotic microangiopathy, and hypertension following T cell-depleted hematopoietic stem cell transplantation","volume":"16","author":"Glezerman","year":"2010","journal-title":"Biol Blood Marrow Transplant."},{"key":"B48","doi-asserted-by":"publisher","first-page":"1076","DOI":"10.1016\/j.bbmt.2008.05.022","article-title":"Low body mass index is an independent risk factor for transplant-associated microangiopathy following total-body irradiation-based conditioning regimens","volume":"14","author":"Kaloyannidis","year":"2008","journal-title":"Biol Blood Marrow Transplant."},{"key":"B49","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1016\/j.bbmt.2004.03.002","article-title":"Thrombotic microangiopathy after allogeneic stem cell transplantation in the era of reduced-intensity conditioning: the incidence is not reduced","volume":"10","author":"Shimoni","year":"2004","journal-title":"Biol Blood Marrow Transplant."},{"key":"B50","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1182\/blood.V100.1.334","article-title":"Fludarabine induces apoptosis, activation, and allogenicity in human endothelial and epithelial cells: protective effect of defibrotide","volume":"100","author":"Eissner","year":"2002","journal-title":"Blood."},{"key":"B51","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1038\/bmt.2010.53","article-title":"High fludarabine exposure and relationship with treatment-related mortality after nonmyeloablative hematopoietic cell transplantation","volume":"46","author":"Long-Boyle","year":"2011","journal-title":"Bone Marrow Transplant."},{"key":"B52","doi-asserted-by":"publisher","first-page":"1701","DOI":"10.1016\/j.bbmt.2017.06.021","article-title":"Pharmacokinetics and model-based dosing to optimize fludarabine therapy in pediatric hematopoietic cell transplant recipients","volume":"23","author":"Ivaturi","year":"2017","journal-title":"Biol Blood Marrow Transplant."},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1038\/s41409-018-0298-y","article-title":"Veno-occlusive disease after high-dose busulfan\u2013melphalan in neuroblastoma","author":"Schechter","year":"2018","journal-title":"Bone Marrow Transplant."},{"key":"B54","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1016\/j.bbmt.2005.04.007","article-title":"Sirolimus and thrombotic microangiopathy after allogeneic hematopoietic stem cell transplantation","volume":"11","author":"Cutler","year":"2005","journal-title":"Biol Blood Marrow Transplant"},{"key":"B55","doi-asserted-by":"publisher","first-page":"1439","DOI":"10.1016\/j.bbmt.2013.07.001","article-title":"Distinct deleterious effects of cyclosporine and tacrolimus and combined tacrolimus\u2013sirolimus on endothelial cells: protective effect of defibrotide","volume":"19","author":"Carmona","year":"2013","journal-title":"Biol Blood Marrow Transplant."},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1038\/s41409-018-0293-3","article-title":"High mortality in hematopoietic stem cell transplant-associated thrombotic microangiopathy with and without concomitant acute graft-versus-host disease","author":"Kraft","year":"2018","journal-title":"Bone Marrow Transplant."},{"key":"B57","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1056\/NEJMoa1213299","article-title":"ST2 as a marker for risk of therapy-resistant graft-versus-host disease and death","volume":"369","author":"Vander Lugt","year":"2013","journal-title":"N Engl J Med."},{"key":"B58","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.1056\/NEJMc1700185","article-title":"ST2 and Endothelial injury as a link between GVHD and microangiopathy","volume":"376","author":"Rotz","year":"2017","journal-title":"N Engl J Med"},{"key":"B59","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.beha.2008.02.002","article-title":"Vascular endothelium as \u2018novel\u2019 target of graft-versus-host disease","volume":"21","author":"Tichelli","year":"2008","journal-title":"Pract Res Clin Haematol"},{"key":"B60","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.bbmt.2012.09.018","article-title":"Endothelial vulnerability and endothelial damage are associated with risk of graft-versus-host disease and response to steroid treatment","volume":"19","author":"Dietrich","year":"2013","journal-title":"Biol Blood Marrow Transplant."},{"key":"B61","doi-asserted-by":"publisher","first-page":"1685","DOI":"10.1182\/blood-2011-02-334821","article-title":"Steroid-refractory GVHD: T-cell attack within a vulnerable endothelial system","volume":"118","author":"Luft","year":"2011","journal-title":"Blood"},{"key":"B62","doi-asserted-by":"publisher","first-page":"1671","DOI":"10.1016\/j.bbmt.2016.06.002","article-title":"Healthcare burden, risk factors, and outcomes of mucosal barrier injury laboratory-confirmed bloodstream infections after stem cell transplantation","volume":"22","author":"Dandoy","year":"2016","journal-title":"Biol Blood Marrow Transplant."},{"key":"B63","doi-asserted-by":"publisher","first-page":"1683","DOI":"10.1016\/j.bbmt.2013.09.005","article-title":"Serum neutrophil extracellular trap levels predict thrombotic microangiopathy after allogeneic stem cell transplantation","volume":"19","author":"Arai","year":"2013","journal-title":"Biol Blood Marrow Transplant."},{"key":"B64","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.1182\/blood-2016-09-741298","article-title":"Platelets and neutrophil extracellular traps collaborate to promote intravascular coagulation during sepsis in mice","volume":"129","author":"McDonald","year":"2017","journal-title":"Blood."},{"key":"B65","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1007\/s10238-016-0413-6","article-title":"Granulocyte colony-stimulating factor (G-CSF) increases histone-complexed DNA plasma levels in healthy volunteers","volume":"17","author":"Schoergenhofer","year":"2017","journal-title":"Clin Exp Med."},{"key":"B66","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1038\/sj.bmt.1703879","article-title":"Endothelial damage caused by cytomegalovirus and human herpesvirus-6","volume":"31","author":"Takatsuka","year":"2003","journal-title":"Bone Marrow Transplant."},{"key":"B67","doi-asserted-by":"publisher","first-page":"1512","DOI":"10.1016\/j.bbmt.2011.02.012","article-title":"Blood, and not urine, BK viral load predicts renal outcome in children with hemorrhagic cystitis following hematopoietic stem cell transplantation","volume":"17","author":"Haines","year":"2011","journal-title":"Biol Blood Marrow Transplant"},{"key":"B68","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1038\/sj.bmt.1705164","article-title":"Adenovirus infection rates in pediatric recipients of alternate donor allogeneic bone marrow transplants receiving either antithymocyte globulin (ATG) or alemtuzumab (Campath)","volume":"36","author":"Myers","year":"2005","journal-title":"Bone Marrow Transplant."},{"key":"B69","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1038\/bmt.2017.207","article-title":"Hematopoietic stem cell transplant-associated thrombotic microangiopathy: current paradigm and novel therapies","volume":"53","author":"Khosla","year":"2017","journal-title":"Bone Marrow Transplant."},{"key":"B70","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1016\/S0002-9149(98)00862-5","article-title":"Mechanism by which quinapril improves vascular function in coronary artery disease","volume":"83","author":"Koh","year":"1999","journal-title":"Am J Cardiol."},{"key":"B71","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1309\/AJCPXPD7ZQXNTIAL","article-title":"Effect of blood sampling, processing, and storage on the measurement of complement activation biomarkers","volume":"143","author":"Yang","year":"2015","journal-title":"Am J Clin Pathol"},{"key":"B72","doi-asserted-by":"publisher","first-page":"2182","DOI":"10.1111\/trf.14215","article-title":"Increased complement activation during platelet storage","volume":"57","author":"Chen","year":"2017","journal-title":"Transfusion."},{"key":"B73","doi-asserted-by":"publisher","first-page":"912","DOI":"10.1016\/j.bbmt.2005.07.012","article-title":"Hemolytic uremic syndrome after bone marrow transplantation: clinical characteristics and outcome in children","volume":"11","author":"Hale","year":"2005","journal-title":"Biol Blood Marrow Transplant."},{"key":"B74","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1002\/ajh.20752","article-title":"Recombinant human soluble tumor necrosis factor receptor fusion protein as treatment for steroid refractory graft-versus-host disease following allogeneic hematopoietic stem cell transplantation","volume":"82","author":"Busca","year":"2007","journal-title":"Am J Hematol."},{"key":"B75","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1182\/blood.V84.4.1342.1342","article-title":"Recombinant human interleukin-1 receptor antagonist in the treatment of steroid-resistant graft-versus-host disease","volume":"84","author":"Antin","year":"1994","journal-title":"Blood"},{"key":"B76","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/j.bbmt.2016.11.003","article-title":"Mixed T cell chimerism after allogeneic hematopoietic stem cell transplantation for severe aplastic anemia using an alemtuzumab-containing regimen is shaped by persistence of recipient CD8 T cells","volume":"23","author":"Grimaldi","year":"2017","journal-title":"Biol Blood Marrow Transplant."},{"key":"B77","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1038\/sj.bmt.1705552","article-title":"The influence of cyclosporin alone, or cyclosporin and methotrexate, on the incidence of mixed haematopoietic chimaerism following allogeneic sibling bone marrow transplantation for severe aplastic anaemia","volume":"39","author":"McCann","year":"2006","journal-title":"Bone Marrow Transplant."},{"key":"B78","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1038\/sj.bmt.1705454","article-title":"Replacement of calcineurin inhibitors with daclizumab in patients with transplantation-associated microangiopathy or renal insufficiency associated with graft-versus-host disease","volume":"38","author":"Wolff","year":"2006","journal-title":"Bone Marrow Transplant."},{"key":"B79","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1016\/j.bbmt.2015.10.002","article-title":"Variable eculizumab clearance requires pharmacodynamic monitoring to optimize therapy for thrombotic microangiopathy after hematopoietic stem cell transplantation","volume":"22","author":"Jodele","year":"2016","journal-title":"Biol Blood Marrow Transplant"},{"key":"B80","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1111\/j.1537-2995.2012.03776.x","article-title":"Does early initiation of therapeutic plasma exchange improve outcome in pediatric stem cell transplant\u2013associated thrombotic microangiopathy?","volume":"53","author":"Jodele","year":"2013","journal-title":"Transfusion."},{"key":"B81","doi-asserted-by":"publisher","first-page":"183","DOI":"10.2165\/00003495-200969020-00004","article-title":"Thrombotic microangiopathy in haematopoietic stem cell transplantation","volume":"69","author":"Choi","year":"2009","journal-title":"Drugs"},{"key":"B82","doi-asserted-by":"publisher","first-page":"1038","DOI":"10.1160\/TH10-02-0138","article-title":"Removal of elevated circulating angiopoietin-2 by plasma exchange \u2013 a pilot study in critically ill patients with thrombotic microangiopathy and anti-glomerular basement membrane disease","volume":"104","author":"Lovric","year":"2010","journal-title":"Thromb Haemost"},{"key":"B83","doi-asserted-by":"publisher","first-page":"2172","DOI":"10.1016\/j.bbmt.2017.08.019","article-title":"Thrombotic microangiopathy after allogeneic stem cell transplantation: a comparison of eculizumab therapy and conventional therapy","volume":"23","author":"Bohl","year":"2017","journal-title":"Biol Blood Marrow Transplant"},{"key":"B84","doi-asserted-by":"publisher","first-page":"1337","DOI":"10.1016\/j.bbmt.2016.03.032","article-title":"Terminal complement blockade after hematopoietic stem cell transplantation is safe without meningococcal vaccination","volume":"22","author":"Jodele","year":"2016","journal-title":"Biol Blood Marrow Transplant"},{"key":"B85","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1053\/j.seminhematol.2018.04.003","article-title":"Complement in pathophysiology and treatment of transplant-associated thrombotic microangiopathies","volume":"55","author":"Jodele","year":"2018","journal-title":"Semin Hematol"},{"key":"B86","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1182\/blood-2018-09-876136","article-title":"Ravulizumab (ALXN1210) vs eculizumab in adult patients with PNH naive to complement inhibitors: the 301 study","volume":"133","author":"Lee","year":"2018","journal-title":"Blood"},{"key":"B87","doi-asserted-by":"publisher","first-page":"970","DOI":"10.1182\/blood-2016-08-732800","article-title":"Incomplete inhibition by eculizumab: mechanistic evidence for residual C5 activity during strong complement activation","volume":"129","author":"Harder","year":"2017","journal-title":"Blood."},{"key":"B88","doi-asserted-by":"publisher","first-page":"1254","DOI":"10.1182\/bloodadvances.2016002832","article-title":"Use of the complement inhibitor Coversin to treat HSCT-associated TMA","volume":"1","author":"Goodship","year":"2017","journal-title":"Blood Adv."},{"key":"B89","doi-asserted-by":"publisher","first-page":"886","DOI":"10.1111\/trf.13437","article-title":"Treatment of thrombotic microangiopathy after hematopoietic stem cell transplantation with recombinant human soluble thrombomodulin","volume":"56","author":"Fujiwara","year":"2016","journal-title":"Transfusion."},{"key":"B90","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1038\/sj.bmt.1703414","article-title":"Defibrotide as a promising treatment for thrombotic thrombocytopenic purpura in patients undergoing bone marrow transplantation","volume":"29","author":"Corti","year":"2002","journal-title":"Bone Marrow Transplant."},{"key":"B91","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1038\/s41409-018-0256-8","article-title":"Use of defibrotide to treat adult patients with transplant-associated thrombotic microangiopathy","volume":"54","author":"Mart\u00ednez-Mu\u00f1oz","year":"2019","journal-title":"Bone Marrow Transplant."},{"key":"B92","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1016\/S0140-6736(11)61938-7","article-title":"Defibrotide for prophylaxis of hepatic veno-occlusive disease in paediatric haemopoietic stem-cell transplantation: an open-label, phase 3, randomised controlled trial","volume":"379","author":"Corbacioglu","year":"2012","journal-title":"Lancet."},{"key":"B93","doi-asserted-by":"publisher","first-page":"1537","DOI":"10.1016\/j.bbmt.2014.05.030","article-title":"Vitamin D levels affect outcome in pediatric hematopoietic stem cell transplantation","volume":"20","author":"Hansson","year":"2014","journal-title":"Biol Blood Marrow Transplant"},{"key":"B94","doi-asserted-by":"publisher","first-page":"1627","DOI":"10.1016\/j.bbmt.2015.06.009","article-title":"Vitamin D deficiency and survival in children after hematopoietic stem cell transplant","volume":"21","author":"Wallace","year":"2015","journal-title":"Biol Blood Marrow Transplant"},{"key":"B95","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1007\/s40618-015-0381-9","article-title":"Vitamin D protects endothelial cells from irradiation-induced senescence and apoptosis by modulating MAPK\/SirT1 axis","volume":"39","author":"Marampon","year":"2016","journal-title":"J Endocrinol Invest."},{"key":"B96","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1038\/sj.bmt.1703226","article-title":"Oral eicosapentaenoic acid for complications of bone marrow transplantation","volume":"28","author":"Takatsuka","year":"2001","journal-title":"Bone Marrow Transplant"},{"key":"B97","doi-asserted-by":"publisher","first-page":"e526-36","DOI":"10.1016\/S2352-3026(16)30114-4","article-title":"Association of busulfan exposure with survival and toxicity after haemopoietic cell transplantation in children and young adults: a multicentre, retrospective cohort analysis","volume":"3","author":"Bartelink","year":"2016","journal-title":"Lancet Haematol."},{"key":"B98","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1038\/clpt.2009.27","article-title":"Personalized dosing of cyclophosphamide in the total body irradiation\u2013cyclophosphamide conditioning regimen: a phase II trial in patients with hematologic malignancy","volume":"85","author":"McCune","year":"2009","journal-title":"Clin Pharmacol Ther"},{"key":"B99","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1016\/j.bbrc.2013.12.007","article-title":"Uric acid induces NADPH oxidase-independent neutrophil extracellular trap formation","volume":"443","author":"Arai","year":"2014","journal-title":"Biochem Biophys Res Commun"},{"key":"B100","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1016\/j.bbmt.2014.02.003","article-title":"Phase I study of urate oxidase in the reduction of acute graft-versus-host disease after myeloablative allogeneic stem cell transplantation","volume":"20","author":"Yeh","year":"2014","journal-title":"Biol Blood Marrow Transplant"},{"key":"B101","doi-asserted-by":"publisher","first-page":"2988","DOI":"10.1182\/blood-2016-03-702803","article-title":"Atorvastatin enhances endothelial cell function in posttransplant poor graft function","volume":"128","author":"Shi","year":"2016","journal-title":"Blood"},{"key":"B102","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1111\/cei.12124","article-title":"The oxidative stress induced in vivo by Shiga toxin-2 contributes to the pathogenicity of haemolytic uraemic syndrome","volume":"173","author":"Gomez","year":"2013","journal-title":"Clin Exp Immunol"},{"key":"B103","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1007\/s11239-015-1259-6","article-title":"The role of N-acetylcysteine in the treatment of thrombotic thrombocytopenic purpura","volume":"41","author":"Rottenstreich","year":"2016","journal-title":"J Thromb Thrombolysis."},{"key":"B104","doi-asserted-by":"publisher","first-page":"2106","DOI":"10.1016\/j.bbmt.2015.07.010","article-title":"CD34-selected hematopoietic stem cell transplants conditioned with myeloablative regimens and antithymocyte globulin for advanced myelodysplastic syndrome: limited graft-versus-host disease without increased relapse","volume":"21","author":"Tamari","year":"2015","journal-title":"Biol Blood Marrow Transplant"},{"key":"B105","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.bbmt.2015.08.034","article-title":"Single-agent post-transplantation cyclophosphamide as graft-versus-host disease prophylaxis after human leukocyte antigen\u2013matched related bone marrow transplantation for pediatric and young adult patients with hematologic malignancies","volume":"22","author":"Jacoby","year":"2016","journal-title":"Biol Blood Marrow Transplant"},{"key":"B106","doi-asserted-by":"publisher","first-page":"1638","DOI":"10.1016\/j.bbmt.2013.09.003","article-title":"In vivo T cell costimulation blockade with abatacept for acute graft-versus-host disease prevention: a first-in-disease trial","volume":"19","author":"Koura","year":"2013","journal-title":"Biol Blood Marrow Transplant"},{"key":"B107","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1001\/jama.2018.12512","article-title":"Effect of levofloxacin prophylaxis on bacteremia in children with acute leukemia or undergoing hematopoietic stem cell transplantation: a randomized clinical trial","volume":"320","author":"Alexander","year":"2018","journal-title":"JAMA."},{"key":"B108","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1038\/sj.bmt.1705425","article-title":"Allogeneic hematopoietic stem cell transplantation after rituximab-containing myeloablative preparative regimen for acute lymphoblastic leukemia","volume":"38","author":"Kebriaei","year":"2006","journal-title":"Bone Marrow Transplant"},{"key":"B109","doi-asserted-by":"publisher","first-page":"1510","DOI":"10.1182\/blood-2013-04-495895","article-title":"Rituximab prophylaxis prevents corticosteroid-requiring chronic GVHD after allogeneic peripheral blood stem cell transplantation: results of a phase 2 trial","volume":"122","author":"Cutler","year":"2013","journal-title":"Blood"},{"key":"B110","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1016\/j.bbmt.2018.01.009","article-title":"Early increase in complement terminal pathway activation marker sC5b-9 is predictive for the development of thrombotic microangiopathy after stem cell transplantation","volume":"24","author":"Horv\u00e1th","year":"2018","journal-title":"Biol Blood Marrow Transplant"},{"key":"B111","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1038\/sj.bmt.1701151","article-title":"Diagnostic value of hemostatic parameters in bone marrow transplant-associated thrombotic microangiopathy","volume":"21","author":"Kanamori","year":"1998","journal-title":"Bone Marrow Transplant"},{"key":"B112","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1038\/sj.bmt.1701928","article-title":"Calpain activity in bone marrow transplant-associated thrombotic thrombocytopenic purpura","volume":"24","author":"Zeigler","year":"1999","journal-title":"Bone Marrow Transplant."},{"key":"B113","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1007\/s00467-018-4178-x","article-title":"Haptoglobin degradation product as a novel serum biomarker for hematopoietic stem cell transplant-associated thrombotic microangiopathy","volume":"34","author":"Schuh","year":"2019","journal-title":"Pediatr Nephrol"}],"container-title":["Frontiers in Pediatrics"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fped.2019.00133\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,11,23]],"date-time":"2019-11-23T08:50:26Z","timestamp":1574499026000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fped.2019.00133\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4,9]]},"references-count":113,"alternative-id":["10.3389\/fped.2019.00133"],"URL":"https:\/\/doi.org\/10.3389\/fped.2019.00133","relation":{},"ISSN":["2296-2360"],"issn-type":[{"value":"2296-2360","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,4,9]]},"article-number":"133"}}